NCT00987792View on ClinicalTrials.gov

CAPRIVI: Community Acquired Pneumonia: Treatment With Avelox® in Hospitalized Patients

CompletedOBSERVATIONAL

Enrollment

2,595

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

June 30, 2011

Study Completion Date

October 31, 2012

Conditions

Pneumonia

Interventions

DRUG

Moxifloxacin (Avelox, BAY12-8039)

Hospitalized patients receiving Avelox according to local drug information

Trial Locations (11)

Unknown

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY

NCT00987792 - CAPRIVI: Community Acquired Pneumonia: Treatment With Avelox® in Hospitalized Patients | Biotech Hunter | Biotech Hunter